BRIEF-IceCure Medical Says FDA Advisory Panel Meeting Date For Marketing Authorization Of ProSense Scheduled For Nov 7

Reuters
12 Sep 2024
IceCure Medical Ltd.1.41%Post-market

Sept 12 (Reuters) - Icecure Medical Ltd :

* ICECURE MEDICAL LTD: FDA ADVISORY PANEL MEETING DATE FOR MARKETING AUTHORIZATION OF PROSENSE SCHEDULED FOR NOVEMBER 7

* ICECURE MEDICAL LTD - FDA DECISION REGARDING MARKETING AUTHORIZATION OF PROSENSE® EXPECTED BY EARLY 2025

Source text for Eikon: Further company coverage:

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

no data

No relevant data is available

If the download button clicks without skipping, click on the top right menu and select "Open in Browser."